Thank you, Lee. On today's call, I'll provide a recap of our third quarter financial performance and review key balance sheet and cash flow metrics. Before getting into the results, I want to note that on July 1, we reached the 1-year anniversary date of the Bacharach acquisition. So the data discussed on the call today and in our filings this quarter are on an organic comparison basis, unless otherwise noted. As Lee mentioned, third quarter sales were up 16% on a constant currency basis. Foreign currency translation was a 4% headwind in the quarter and most pronounced in our International segment, resulting primarily from euro and British pound exposure. Strong growth in orders and ongoing supply chain challenges resulted in a book-to-bill approximately 1.1x and record backlog at the end of the quarter. While we saw some improvements in the supply chain during the quarter, we do not expect a normalized supply chain, at least until well into 2023. Now turning to profitability. Our gross profit margin was 44.4% of sales in the quarter, an increase of 50 basis points over the prior year. Pricing initiatives implemented throughout the year drove healthy improvement in underlying product margins, and this was offset by indirect charges relate inventory and warranty. We continue to be active on the pricing front to keep pace with rising costs in our business. A price increase recently went into effect in October for both segments. SG&A expenses were 21.7% of sales in the quarter compared with 25.7% in the prior year. We had approximately $2 million of favorable nonrecurring adjustments in the quarter. In addition, the prior year amount included transaction expenses related to the Bacharach acquisition. Reported operating margin was 16.8% in the quarter compared to 9.5% of sales in the prior year. On an adjusted basis, operating margin was 19.7% compared to 16% in the prior year. We levered well on the sales increase with incremental margin of 50% in the quarter. On a year-to-date basis, incremental margin was 36%, in line with our targeted range of 30% to 40%. With that, I'll now provide a closer look at the financial performance of our segments. In our Americas segment, sales were up a strong 21% year-over-year and adjusted operating margin improved 640 basis points to 27.2%. The higher sales volume, positive price realization and disciplined cost management shows the margin improvement. In our International segment, reported sales declined 5% year-over-year and adjusted operating margin contracted by 350 basis points to 8%. Currency translation was an 11% headwind on the sales during the quarter. Results were impacted by lower sales volumes, FX headwinds on cross-border purchases and less favorable product mix due to supply chain constraints on gas detection products. Book-to-bill was elevated in more than 1.2x and backlog increased in the quarter. GAAP net income was $45 million or $1.14 per diluted share compared to GAAP net income of $21 million or $0.54 per diluted share in the prior year. On an adjusted basis, adding back restructuring, product liability and similar items, net income was $57 million or $1.45 per diluted share compared to $39 million or $1 per diluted share in the prior year. Now turning to cash flow and the balance sheet. Quarterly free cash flow was $55 million, up 55% compared to a year ago. Year-to-date free cash flow for the first 9 months was $75 million. As we discussed last quarter, we've been carrying an elevated level of inventory throughout the year in response to strong demand, high backlog levels and input shortages. We expect to realize improvements in working capital in the fourth quarter. Quarterly CapEx was $9 million. We paid $18 million of dividends to shareholders and deployed $2 million to repurchase shares in the quarter. Year-to-date, we have returned more than $80 million to shareholders through dividends and share repurchases. Our balance sheet remains strong. At the end of the quarter, we had cash of $160 million and net debt was $445 million or 1.4x adjusted EBITDA for the trailing 12 months. With that, I'll turn the call back over to Nish for closing remarks. Nish?